Therapeutic Goods Amendment (2022 Measures No. 1) Bill 2022
Became law
| Act | Therapeutic Goods Amendment (2022 Measures No. 1) Act 2023 |
|---|---|
| Number | No. 10, 2023 |
| Assent | 21 Mar 2023 |
| Status | In force |
Sourced from the Federal Register of Legislation at 21 Nov 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.
Progress
| Date | Step |
|---|---|
| House | |
| 1 Dec 2022 | Introduced and read a first time |
| 1 Dec 2022 | Second reading moved |
| 7 Feb 2023 | Second reading debate |
| 7 Feb 2023 | Referred to Federation Chamber |
| 8 Feb 2023 | Second reading debate |
| 8 Feb 2023 | Second reading agreed to |
| 8 Feb 2023 | Reported from Federation Chamber |
| 8 Feb 2023 | Third reading agreed to |
| Senate | |
| 9 Feb 2023 | Introduced and read a first time |
| 9 Feb 2023 | Second reading moved |
| 7 Mar 2023 | Second reading debate |
| 8 Mar 2023 | Second reading debate |
| 9 Mar 2023 | Second reading debate |
| 9 Mar 2023 | Second reading agreed to |
| 9 Mar 2023 | Committee of the Whole debate |
| 9 Mar 2023 | Third reading agreed to |
| House | |
| 9 Mar 2023 | Message from Senate reported |
| 9 Mar 2023 | Consideration of Senate message |
| 9 Mar 2023 | Finally passed both Houses |
| 21 Mar 2023 | Assent |
Amends the Therapeutic Goods Act 1989 to:
- require mandatory reporting of adverse events involving medical devices
- provide a marketing approval pathway for biologicals that are for export only
- remove merits review rights for a decision by the secretary to require a person to provide information or documents under the Act
- enable the secretary to extend the period for a person to pay the amount stated in an infringement notice, and require a person to provide information or documents that are relevant to a contravention of the Act
- extend the period for which seized goods can be held
- provide that therapeutic goods advertising is excluded from advertising restrictions for certain health professionals or to persons purchasing goods on behalf of governments, registered charities or health facilities
- enable the secretary to withdraw approval for the use of a restricted representation in an advertisement about therapeutic goods
- enable the secretary to approve the importation or supply of substitute overseas prescription medicine that has been previously approved within Australia
- provide that the secretary is not required to observe any requirements of the natural justice hearing rule when releasing therapeutic goods information
- provide that sponsors of reportable medicines that are in shortage must provide updated information to the secretary
- make technical amendments.
Summary from the official bill homepage.
Documents
Official record: bill homepage at aph.gov.au, full text and documents on ParlInfo.